Trial Profile
Multicentric Study of GOELAMS Phase I Evaluation of RAD001 in Association With Aracytine and Daunorubicine in AML Treatment in Patients Less Than 65 Years in Relapse More Than One Year After First Complete Remission.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2011 Official Title amended as reported by ClinicalTrials.gov.
- 11 May 2011 New trial record.